N/A
Completed N=550
Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV
HIV · Viremia · Pregnancy Related
Source: ClinicalTrials.gov NCT05845619 ↗
Enrolled (actual)
550
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcomePrimary: Plasma HIV RNA >50 Copies/mL — 34; 13; 15 Participants — p=0.33
Summary
The goal of this study is to learn about supporting pregnant and postpartum women living with HIV with treatment adherence. The investigators will conduct a pilot study of an intervention that includes peer counseling about viral load levels and rapid delivery of viral load results. The investigators will evaluate the feasibility of the intervention, and will assess whether it improves viral suppression 6 months following the intervention, compared to historical controls.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Plasma HIV RNA >50 Copies/mL |
34; 13; 15 | 0.33 |
Eligibility Criteria
Inclusion Criteria
- Women living with HIV
- On antiretroviral treatment
- Either pregnant in the 3rd trimester, OR, postpartum within 6 months of delivery
Exclusion Criteria
- n/a
Data sourced from ClinicalTrials.gov (NCT05845619). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.